Undetectable equals untransmittable (U=U) has improved HIV prevention and tackled stigma, but there are still a few questions to answer.
"We don't need to spend another $140 million to find out how to retain people in care," activist David Barr writes. "We need to invest in the kinds of services people need so that they can use treatment easily and effectively."
The global increase in sexually transmitted infections was a major focus of the CROI 2019 meeting in Seattle, Washington.
TheBodyPro is covering all the latest in HIV science at the biggest annual gathering of HIV researchers in the U.S. Here's a preview of what's to come.
Efavirenz (Sustiva, Stocrin) alters hormone exposure from the vaginal ring in HIV positive women, similar or greater to that previously reported with oral hormonal contraceptives.
Most people who could benefit from pre-exposure prophylaxis are not accessing it, the U.S. Centers for Disease Control and Prevention revealed at this year's Conference on Retroviruses and Opportunistic Infections.
Rob Newells, executive director of the AIDS Project of the East Bay, gives his personal (U.S.-centered, black MSM-focused) highlights from CROI 2018.
“CROI clearly remains our best meeting,” writes Paul E. Sax, M.D., “the only one that brings together so much high quality research from so many disciplines.”
Gina Brown, M.D., shares her reflections on some of the many research findings about HIV prevention, care, and treatment for women and girls presented at CROI 2018.
Three video interviews with federal HIV leaders who shared perspectives about the science coming out of the conference and its implications for HIV prevention, care, and treatment.